Expression of co-stimulators CD28/B7-1 in peripheral blood of patients with breast cancer

Breast Cancer Research and Treatment

Volumn 136, Issue 2, 2012, Pages 621-622

  Gong, Jian ^a   Pan, Wen ^a   Yang, Chuanjia ^a   Guo, Feng ^a   Sun, Yunping ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CD28 ANTIGEN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA;

BLOOD; BREAST CANCER; BREAST CARCINOMA; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CCND1 GENE; CLINICAL EVALUATION; EARLY CANCER; GENE; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNOSURVEILLANCE; INNATE IMMUNITY; LETTER; METASTASIS; MINIMALLY INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD28; ANTIGENS, CD80; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOPHENOTYPING; T-LYMPHOCYTES;

EID: 84868212246     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2267-2     Document Type: Letter

References (3)

1. Quintayo MA, Munro AF, Thomas J et al (2012) GSK3b and cyclin D1 expression predicts outcome in early breast cancer patients. Breast Cancer Res Treat. doi:10.1007/s10549-012-2229-8
2. Burnet FM (1970) The concept of immunological surveillance. Prog Exp Tumor Res 13:1-27
3. Rabinowich H, Reichert TE, Kashii Y et al (1998) Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. J Clin Invest 101:2579-2588